Who is 'John F. Nash Jr.'
John F. Nash, Jr., was an American mathematician who won the 1994 Nobel Prize in Economics, along with John Harsanyi and Reinhard Selten, for his development of the mathematical foundations of game theory. Nash was also a pioneer in the study of study of differential geometry and partial differential equations. He also developed an equilibrium theory known as the Nash Equilibrium (of which the prisoner's dilemma is a wellknown example).
BREAKING DOWN 'John F. Nash Jr.'
John F. Nash, Jr., was born in Bluefield, West Virginia, in 1928. He trained not as an economist but as a mathematician, earning his Ph.D. in mathematics from Princeton at the age of 22. He taught math at the Massachusetts Institute of Technology and worked for the RAND Corporation, but his paranoid schizophrenia negatively affected his career for more than two decades.
By the early 1970s, Nash received treatment that allowed his condition to improve to the point that he was able to begin teaching again at Princeton. It was there that he served as senior research mathematician for the last 20 years of his life. There, he later became known as the "Phantom of Fine Hall" for his habit of filling blackboards with complex equations during the night when no one else was around.
John F. Nash Jr. and Other Work and Legacy
Among Nash's other groundbreaking math theories: the NashMoser inverse function theorem, the Nash–De Giorgi theorem, the Nash embedding theorems, which the Norwegian Academy of Science and Letters said were "among the most original results in geometric analysis of the twentieth century”.
The 2001 Nash gained worldwide popular recognition thanks to the Academy Awardwinning film "A Beautiful Mind," which chronicles the lives of him and his wife, Alicia, as they struggled between his genius and his mental illness. It was based on the 1998 biography by Sylvia Nasar.
In 2015, John and Alicia Nash were killed when the taxi they were riding in crashed in New Jersey. He was 86 and she was 82. They had been returning from Norway, where Nash had been awarded the prestigious 2015 Abel Prize from the Norwegian Academy of Science and Letters.
Twenty years earlier, upon accepting the Nobel Prize for Mathematics, Nash offered a speech that looked back on his tumultuous but accomplished life and concluded:
"Statistically, it would seem improbable that any mathematician or scientist, at the age of 66, would be able through continued research efforts, to add much to his or her previous achievements. However I am still making the effort and it is conceivable that with the gap period of about 25 years of partially deluded thinking providing a sort of vacation my situation may be atypical. Thus I have hopes of being able to achieve something of value through my current studies or with any new ideas that come in the future."

Robert J. Aumann
Robert J Aumann is a mathematician and economist famous for his ... 
Nobel Memorial Prize In Economic ...
The Nobel Memorial Prize in Economic Sciences is a prestigious ... 
ZeroSum Game
A situation in which one person’s gain is equivalent to another’s ... 
Game Theory
Game theory is a framework for modeling scenarios in which conflicts ... 
Ronald H. Coase
Ronald H. Coase was a British economist who won the 1991 Nobel ... 
Merton Miller
Merton Miller was a noted economist who received the Nobel Prize ...

Investing
Gilead Sciences to Focus on NASH and HIV Drugs
Gilead will continue to develop NASH and HIV drugs in 2017. 
Investing
Will This Drug Beat Gilead to Market in NASH? (GILD, ICPT)
A race of sorts is on between Gilead Sciences (NASDAQ: GILD) and Intercept Pharmaceuticals (NASDAQ: ICPT). In a bid to be the first to win approval for a medicine for the treatment of nonalcoholic ... 
Investing
Gilead Pays $200M Milestone for Liver Drug (GILD)
Gilead Sciences made a $200 million milestone payment to Nimbus Therapeutics for its drug to treat fatty liver disease. 
Investing
BristolMyers Sinks $100M in NASH, Fibrosis (BMY)
BristolMyers will pay $100 million to Japanese drug firm Nitto to develop a liver fibrosis drug. 
Insights
Galectin Tanks on Failure of NASH Treatment (GALT)
Galectin shares plunge after test results on advanced fibrosis patients miss their primary goal. 
Investing
Allergan Buys 2 Liver DiseaseFocused Biopharmas
The big pharmaceutical company that loves to acquire smaller peers is at it again. Allergan (NYSE: AGN) announced that it has signed deals for not one, but a pair of small complementary acquisitions. ... 
Investing
4 Reasons Intercept Pharmaceuticals Should Be on Your Radar (ICPT)
Learn about Intercept Pharmaceuticals and what type of biopharmaceuticals it seeks to create. Understand four reasons why the company is a good investment. 
Investing
Fidelity Investments Charitable Trust Has Received $22M Worth of Bitcoin This Year
Fidelity Investments Charitable Trust has received $22 million in bitcoin donations this year. 
Investing
Nobel Winners Are Economic Prizes
Before you try to profit from their theories, you should learn about the creators themselves. 
Insights
Game Theory And The Greece Bank Crisis
How can game theory help us understand how the Greece bank crisis will play out? As things come to a head, Greece and the Europeans are trying to hold out.

What is the difference between a dominant strategy solution and a Nash equilibrium ...
Dive into game theory and the Nash equilibrium, and learn why the equilibrium assumptions about information are less important ... Read Answer >> 
Why is game theory useful in business?
The concepts of game theory became a revolutionary interdisciplinary phenomenon, but they are still relevant for business ... Read Answer >> 
What is general equilibrium theory in macroeconomics?
Achieving equilibrium of prices in a single or multimarket setting involves a bidding process that is informed precisely ... Read Answer >>